Coverage
-
August 10, 2015
Novartis Pharmaceutical Corp. suffered a defeat Friday in its patent suit against generic-drug maker Zydus Noveltech Inc. over the Exelon dementia treatment patch, when a Delaware federal judge dismissed the case because it originated in New Jersey.
1 other articles on this case.
View all »